General Information of the Compound
Compound ID
CP0860751
Compound Name
4-((6-chloro-2-phenylimidazo[1,2-a]pyridin-3-yl)methyl)-2,6-dimethylmorpholine
    Show/Hide
Structure
Formula
C20H22ClN3O
Molecular Weight
355.869
Canonical SMILES
CC1CN(Cc2c(-c3ccccc3)nc3ccc(Cl)cn23)CC(C)O1
    Show/Hide
InChI
InChI=1S/C20H22ClN3O/c1-14-10-23(11-15(2)25-14)13-18-20(16-6-4-3-5-7-16)22-19-9-8-17(21)12-24(18)19/h3-9,12,14-15H,10-11,13H2,1-2H3
    Show/Hide
InChIKey
OJLRJNGOQDIRQI-UHFFFAOYSA-N
Physicochemical Property
logP
4.2639
Rotatable Bonds
3
Heavy Atom Count
25
Polar Areas
29.77
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 3709027
ChEMBL ID
CHEMBL4294751
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04657, Solute carrier family 2, facilitated glucose transporter member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS